Patients should be advised not to wear a contact lens if their eye is red. should not be used to treat contact lens-related irritation.
LASTACAFT™
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Alcaftadine is a white to yellow powder with an empirical formula of CHNO and a molecular weight of 307.39.
The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Clinical efficacy was evaluated in conjunctival allergen challenge (CAC) studies. was more effective than its vehicle in preventing ocular itching in patients with allergic conjunctivitis induced by an ocular allergen challenge, both at 3 minutes post-dosing and at 16 hours post-dosing of .
The safety of was evaluated in a randomized clinical study of 909 subjects over a period of 6 weeks.
For topical ophthalmic administration only.
ALLERGAN
72409US10B
Relabeling and Repackaging by:
